Our research focuses on prostate cancer and personalized medicine. We use next- generation sequencing and other technologies for molecular profiling of tumor, blood, and urine samples from patients. We also run clinical trials. The overall aim is to develop novel biomarkers and obtain new insights into tumor biology.
